oxotremorine has been researched along with Lung Neoplasms in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Group 1 patients suffered from moderate COPD (mean FEV1 56%; range 34-71%; mean pack years of cigarette smoking 50, range 20-96; one non-smoker)." | 1.34 | Dysfunctional inhibitory muscarinic receptors mediate enhanced histamine release in isolated human bronchi. ( Buhl, R; Hölper, B; Kilbinger, H; Kirkpatrick, CJ; Kortsik, C; Wessler, I, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wessler, I | 1 |
| Hölper, B | 1 |
| Kortsik, C | 1 |
| Buhl, R | 1 |
| Kilbinger, H | 1 |
| Kirkpatrick, CJ | 1 |
1 other study available for oxotremorine and Lung Neoplasms
| Article | Year |
|---|---|
Dysfunctional inhibitory muscarinic receptors mediate enhanced histamine release in isolated human bronchi.
Topics: Acetylcholine; Aged; Bronchi; Calcimycin; Female; Forced Expiratory Volume; Histamine Release; Human | 2007 |